Prot# CYC682-12 (A2): A Phase III Randomized Study of Oral Sapacitabine in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia.

Project: Research project

Project Details

StatusFinished
Effective start/end date6/15/116/15/17

Funding

  • Cyclacel Ltd. (CYC682-12 (A2))